Yeonggul Jang1, Iksung Cho2, Bríain W Ó Hartaigh3,4, Se-Il Park5, Youngtaek Hong1, Sanghoon Shin2, Seongmin Ha1, Byunghwan Jeon1, Hoyup Jung6, Hackjoon Shim7, James K Min3, Hyuk-Jae Chang2,7, Yangsoo Jang2, Namsik Chung2,8. 1. Brain Korea 21 Project for Medical Science, Yonsei University, Seoul, Korea. 2. Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 250 Seongsanno, Seodaemungu, Seoul 120-752, Korea. 3. Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York, NY, USA. 4. Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, Adler Geriatric Center, New Haven, CT, USA. 5. Cardiovascular Product Evaluation Center, Yonsei University College of Medicine, Seoul, Korea. 6. Department of Computer Science and Engineering, Hankuk University of Foreign Studies, Kyonggi, 449-791, Korea. 7. Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea. 8. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND: Given the lack of promptness and inevitable use of additional contrast agents, the myocardial viability imaging procedures have not been used widely for determining the need to performing revascularization. OBJECTIVE: This study is aimed to evaluate the feasibility of myocardial viability assessment, consecutively with diagnostic invasive coronary angiography (ICA) without use of additional contrast agent, using a novel hybrid system comprising ICA and multislice CT (MSCT). METHODS: In all, 14 Yucatan miniature swine models (female; age, 3 months; weight, 28-30 kg) were subjected to ICA followed by balloon occlusion (90 minutes) and reperfusion of the left anterior descending coronary artery. Two weeks after induction of myocardial infarction, delayed hyperenhancement (DHE) images were obtained, using a novel combined machine comprising ICA and 320-channel MSCT scanner (Aquilion ONE, Toshiba), after 2, 5, 7, 10, 15, and 20 minutes after conventional ICA. The heart was sliced in 10-mm consecutive sections in the short-axis plane and was embedded in a solution of 1% triphenyltetrazolium chloride (TTC). Infarct size was determined as TTC-negative areas as a percentage of total left ventricular area. On MSCT images, infarct size per slice was calculated by dividing the DHE area by the total slice area (%) and compared with histochemical analyses. RESULTS: Serial MSCT scans revealed a peak CT attenuation of the infarct area (222.5 ± 36.5 Hounsfield units) with a maximum mean difference in CT attenuation between the infarct areas and normal myocardium of at 2 minutes after contrast injection (106.4; P for difference = 0.002). Furthermore, the percentage difference of infarct size by MSCT vs histopathologic specimen was significantly lower at 2 (8.5% ± 1.8%) and 5 minutes (9.5% ± 1.9%) than those after 7 minutes. Direct comparisons of slice-matched DHE area by MSCT demonstrated excellent correlation with TTC-derived infarct size (r = 0.952; P < .001). Bland-Altman plots of the differences between DHE by MSCT and TTC-derived infarct measurements plotted against their means showed good agreement between the 2 methods. CONCLUSION: The feasibility of myocardial viability assessment by DHE using MSCT after conventional ICA was proven in experimental models, and the optimal viability images were obtained after 2 to 5 minutes after the final intracoronary injection of contrast agent for conventional ICA.
BACKGROUND: Given the lack of promptness and inevitable use of additional contrast agents, the myocardial viability imaging procedures have not been used widely for determining the need to performing revascularization. OBJECTIVE: This study is aimed to evaluate the feasibility of myocardial viability assessment, consecutively with diagnostic invasive coronary angiography (ICA) without use of additional contrast agent, using a novel hybrid system comprising ICA and multislice CT (MSCT). METHODS: In all, 14 Yucatan miniature swine models (female; age, 3 months; weight, 28-30 kg) were subjected to ICA followed by balloon occlusion (90 minutes) and reperfusion of the left anterior descending coronary artery. Two weeks after induction of myocardial infarction, delayed hyperenhancement (DHE) images were obtained, using a novel combined machine comprising ICA and 320-channel MSCT scanner (Aquilion ONE, Toshiba), after 2, 5, 7, 10, 15, and 20 minutes after conventional ICA. The heart was sliced in 10-mm consecutive sections in the short-axis plane and was embedded in a solution of 1% triphenyltetrazolium chloride (TTC). Infarct size was determined as TTC-negative areas as a percentage of total left ventricular area. On MSCT images, infarct size per slice was calculated by dividing the DHE area by the total slice area (%) and compared with histochemical analyses. RESULTS: Serial MSCT scans revealed a peak CT attenuation of the infarct area (222.5 ± 36.5 Hounsfield units) with a maximum mean difference in CT attenuation between the infarct areas and normal myocardium of at 2 minutes after contrast injection (106.4; P for difference = 0.002). Furthermore, the percentage difference of infarct size by MSCT vs histopathologic specimen was significantly lower at 2 (8.5% ± 1.8%) and 5 minutes (9.5% ± 1.9%) than those after 7 minutes. Direct comparisons of slice-matched DHE area by MSCT demonstrated excellent correlation with TTC-derived infarct size (r = 0.952; P < .001). Bland-Altman plots of the differences between DHE by MSCT and TTC-derived infarct measurements plotted against their means showed good agreement between the 2 methods. CONCLUSION: The feasibility of myocardial viability assessment by DHE using MSCT after conventional ICA was proven in experimental models, and the optimal viability images were obtained after 2 to 5 minutes after the final intracoronary injection of contrast agent for conventional ICA.
Authors: Albert C Lardo; Marco A S Cordeiro; Caterina Silva; Luciano C Amado; Richard T George; Anastasios P Saliaris; Karl H Schuleri; Veronica R Fernandes; Menekhem Zviman; Saman Nazarian; Henry R Halperin; Katherine C Wu; Joshua M Hare; Joao A C Lima Journal: Circulation Date: 2006-01-24 Impact factor: 29.690
Authors: Timo Baks; Filippo Cademartiri; Amber D Moelker; Annick C Weustink; Robert-Jan van Geuns; Nico R Mollet; Gabriel P Krestin; Dirk J Duncker; Pim J de Feyter Journal: J Am Coll Cardiol Date: 2006-06-09 Impact factor: 24.094
Authors: Timo Baks; Filippo Cademartiri; Amber D Moelker; Willem J van der Giessen; Gabriel P Krestin; Dirk J Duncker; Pim J de Feyter Journal: AJR Am J Roentgenol Date: 2007-02 Impact factor: 3.959
Authors: R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: Arno Buecker; Marcus Katoh; Gabriele A Krombach; Elmar Spuentrup; Philipp Bruners; Rolf W Günther; Thoralf Niendorf; Andreas H Mahnken Journal: Invest Radiol Date: 2005-11 Impact factor: 6.016
Authors: Christoph Klein; Thaiz R Schmal; Stephan G Nekolla; Bernhard Schnackenburg; Eckart Fleck; Eike Nagel Journal: J Cardiovasc Magn Reson Date: 2007 Impact factor: 5.364
Authors: Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko Journal: J Am Coll Cardiol Date: 2007-10-10 Impact factor: 24.094
Authors: Kiran R Nandalur; Ben A Dwamena; Asim F Choudhri; Mohan R Nandalur; Ruth C Carlos Journal: J Am Coll Cardiol Date: 2007-09-17 Impact factor: 24.094
Authors: David Lopez; Jonathan A Pan; Peter M Pollak; Samantha Clarke; Christopher M Kramer; Mark Yeager; Michael Salerno Journal: NMR Biomed Date: 2017-02-06 Impact factor: 4.044